193 related articles for article (PubMed ID: 25629162)
1. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions.
Shaw AK; Pickup MW; Chytil A; Aakre M; Owens P; Moses HL; Novitskiy SV
PLoS One; 2015; 10(1):e0117908. PubMed ID: 25629162
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
Yang L; Huang J; Ren X; Gorska AE; Chytil A; Aakre M; Carbone DP; Matrisian LM; Richmond A; Lin PC; Moses HL
Cancer Cell; 2008 Jan; 13(1):23-35. PubMed ID: 18167337
[TBL] [Abstract][Full Text] [Related]
4. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
5. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
[TBL] [Abstract][Full Text] [Related]
6. Myeloid Cell-Derived TGFβ Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms.
Vasiukov G; Novitskaya T; Zijlstra A; Owens P; Ye F; Zhao Z; Moses HL; Blackwell T; Feoktistov I; Novitskiy SV
Cancer Res; 2020 Jun; 80(12):2628-2638. PubMed ID: 32312837
[TBL] [Abstract][Full Text] [Related]
7. Premetastatic soil and prevention of breast cancer brain metastasis.
Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
[TBL] [Abstract][Full Text] [Related]
8. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
9. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties.
Novitskiy SV; Pickup MW; Chytil A; Polosukhina D; Owens P; Moses HL
J Leukoc Biol; 2012 Sep; 92(3):641-51. PubMed ID: 22685318
[TBL] [Abstract][Full Text] [Related]
10. [Mesenchymal stem cells promote mouse breast tumor progression by inducing the suppressive function of myeloid-derived CD11b⁺ Gr1⁺ cells].
Hu X; Luo Y; Zhou Y; Zhao D; Wu W; Han Z; Feng X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):785-8. PubMed ID: 25108426
[TBL] [Abstract][Full Text] [Related]
11. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Cancer Res; 2007 May; 67(10):4869-77. PubMed ID: 17495323
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
[TBL] [Abstract][Full Text] [Related]
13. Vascular alterations upon activation of TGFbeta signaling in fibroblasts--implications for systemic sclerosis.
Horn A; Distler JH
Arthritis Res Ther; 2010; 12(3):125. PubMed ID: 20602813
[TBL] [Abstract][Full Text] [Related]
14. Adenosine/TGFβ axis in regulation of mammary fibroblast functions.
Vasiukov G; Menshikh A; Owens P; Novitskaya T; Hurley P; Blackwell T; Feoktistov I; Novitskiy SV
PLoS One; 2021; 16(6):e0252424. PubMed ID: 34101732
[TBL] [Abstract][Full Text] [Related]
15. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
[TBL] [Abstract][Full Text] [Related]
16. TGF-β signaling in myeloid cells is required for tumor metastasis.
Pang Y; Gara SK; Achyut BR; Li Z; Yan HH; Day CP; Weiss JM; Trinchieri G; Morris JC; Yang L
Cancer Discov; 2013 Aug; 3(8):936-51. PubMed ID: 23661553
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer modulates the immunosuppressive function of CD11b
Udumula MP; Sakr S; Dar S; Alvero AB; Ali-Fehmi R; Abdulfatah E; Li J; Jiang J; Tang A; Buekers T; Morris R; Munkarah A; Giri S; Rattan R
Mol Metab; 2021 Nov; 53():101272. PubMed ID: 34144215
[TBL] [Abstract][Full Text] [Related]
18. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
19. miR-130a and miR-145 reprogram Gr-1
Ishii H; Vodnala SK; Achyut BR; So JY; Hollander MC; Greten TF; Lal A; Yang L
Nat Commun; 2018 Jul; 9(1):2611. PubMed ID: 29973593
[TBL] [Abstract][Full Text] [Related]
20. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
